---
abstract: A significant number of women with serous ovarian cancer are intrinsically
  refractory to platinum-based treatment. We analyzed somatic DNA copy number variation
  and gene expression data to identify key mechanisms associated with primary resistance
  in advanced-stage serous cancers.
authors: Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, Getz G, Tothill
  R, Okamoto A, Raeder MB, Harnett P, Lade S, Akslen LA, Tinker AV, Locandro B, Alsop
  K, Chiew YE, Traficante N, Fereday S, Johnson D, Fox S, Sellers W, Urashima M, Salvesen
  HB, Meyerson M and Bowtell D.
contact:
  email: d.bowtell@petermac.org
  name: David Bowtell
counts:
  biosamples: 118
  samples_acgh: 118
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:19193619
- geo:GSE13813
geo_data:
  geo_json:
    coordinates:
    - 144.96
    - -37.81
    type: Point
  info:
    city: Melbourne
    continent: Australia
    country: Australia
    label: Melbourne, Australia, Australia
    precision: city
journal: 'Clin Cancer Res 15, 4 (2009): 1417-27.'
label: 'Etemadmoghadam et al. (2009): Integrated Genome-Wide DNA Copy Number and Expression
  Analysis Identifies Distinct ...'
notes: ~
pmid: 19193619
title: Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct
  Mechanisms of Primary Chemoresistance in Ovarian Carcinomas.
year: 2009
